ABLI — Abliva AB Share News
0.000.00%
Last trade - 00:00- SEK467.94m
- SEK435.27m
Brief: Abliva Applies For Delisting
Brief: Abliva Proposes No Dividend For 2024
Brief: Abliva Q4 EPS SEK -0.02
Brief: Abliva Board Recommends Shareholders To Accept Public Cash Offer
Brief: Abliva Q3 EPS SEK -0.01
Brief: Abliva Q1 EPS SEK -0.02
Brief: Abliva Publishes Rights Issue Outcome
Brief: Abliva Q4 EPS SEK -0.02
Brief: Abliva Resolves On Capital Raise Of About SEK 88 Mln
Brief: Abliva Proposes No Dividends For 2023
Brief: Abliva Receives Orphan Designation From European Commission For NV354
Brief: Abliva Q3 Pre-tax Loss Widens To SEK 32.9 Mln
Brief: Abliva Q3 EPS SEK -0.03
Brief: Abliva And Owl Therapeutics Enter Licensing And Collaboration Agreement
Brief: Abliva: Lead Candidate Kl1333 Receives FDA Fast Track Designation
Brief: Abliva Q2 Loss Before Tax Widens To SEK 21.2 Mln
Brief: Abliva Q2 EPS at SEK -0.02
Brief: Abliva Q1 Pre-Tax Loss Narrows To SEK 16.1 Mln
Brief: Abliva Q1 EPS at SEK -0.02